🇺🇸 FDA
Patent

US 11129828

Pyridazinone compounds and their use as DAAO inhibitors

granted A61KA61K31/50A61K31/501

Quick answer

US patent 11129828 (Pyridazinone compounds and their use as DAAO inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/50, A61K31/501, A61K45/06, A61P